Bioorganic and Medicinal Chemistry Letters p. 2023 - 2026 (2002)
Update date:2022-07-29
Topics:
Spencer, Jeffrey R
McGee, Danny
Allen, Darin
Katz, Bradley A
Luong, Christine
Sendzik, Martin
Squires, Neil
Mackman, Richard L
The structure-based design of potent and selective urokinase-type plasminogen activator (uPA) inhibitors with 4-aminoarylamidine or 4-aminoarylguanidine S1 binding groups, is described.
View MoreImprove Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Jiangxi Dongbang Pharmaceutical Co., Ltd.
Contact:+86-795-4433603, 4433388
Address:Fengxin Industrial Park, Fengxin County, Jiangxi Province, P.R.C
Taimai Sanluck Pharmaceutical Co.,Ltd
Contact:86-592-7662921
Address:8D,No.186,Huarong Road,Huli,Xiamen,China
Shanghai Longjin Metallic Material Co., Ltd.
website:http://www.shlongjin.cn/
Contact:021-56517503,56502257
Address:No.16, Lane 555, Chengyin Road, Shanghai
Doi:10.1002/prac.199533701140
(1995)Doi:10.1016/S0040-4020(01)82537-0
(1968)Doi:10.1016/j.bmcl.2012.09.080
(2012)Doi:10.1021/ja953771p
(1996)Doi:10.1016/0040-4039(95)02105-1
(1996)Doi:10.1007/BF00807069
(1995)